Schaber Marc, Leichtfried Veronika, Fries Dietmar, Wille Maria, Gatterer Hannes, Faulhaber Martin, Würtinger Philipp, Schobersberger Wolfgang
Institute for Sports Medicine, Alpine Medicine and Health Tourism, University for Health Sciences, Medical Informatics and Technology (UMIT), Eduard-Wallnöfer-Zentrum 1, 6060 Hall, Austria.
Department for General and Surgical Critical Care Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Biomed Res Int. 2015;2015:593938. doi: 10.1155/2015/593938. Epub 2015 Sep 15.
The aim of the present study was to investigate whether a 12-hour exposure in a normobaric hypoxic chamber would induce changes in the hemostatic system and a procoagulant state in volunteers suffering from acute mountain sickness (AMS) and healthy controls.
37 healthy participants were passively exposed to 12.6% FiO2 (simulated altitude hypoxia of 4,500 m). AMS development was investigated by the Lake Louise Score (LLS). Prothrombin time, activated partial thromboplastin time, fibrinogen, and platelet count were measured and specific methods (i.e., thromboelastometry and a thrombin generation test) were used.
AMS prevalence was 62.2% (LLS cut off of 3). For the whole group, paired sample t-tests showed significant increase in the maximal concentration of generated thrombin. ROTEM measurements revealed a significant shortening of coagulation time and an increase of maximal clot firmness (InTEM test). A significant increase in maximum clot firmness could be shown (FibTEM test).
All significant changes in coagulation parameters after exposure remained within normal reference ranges. No differences with regard to measured parameters of the hemostatic system between AMS-positive and -negative subjects were observed. Therefore, the hypothesis of the acute activation of coagulation by hypoxia can be rejected.
本研究的目的是调查在常压低氧舱中暴露12小时是否会在患有急性高原病(AMS)的志愿者和健康对照者中引起止血系统的变化和促凝状态。
37名健康参与者被动暴露于12.6%的氧分数(模拟海拔4500米的低氧环境)。通过路易斯湖评分(LLS)调查AMS的发生情况。测量凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原和血小板计数,并使用特定方法(即血栓弹力图和凝血酶生成试验)。
AMS患病率为62.2%(LLS临界值为3)。对于整个组,配对样本t检验显示生成的凝血酶的最大浓度显著增加。血栓弹力图测量显示凝血时间显著缩短,最大血凝块硬度增加(InTEM试验)。最大血凝块硬度显著增加(FibTEM试验)。
暴露后凝血参数的所有显著变化均保持在正常参考范围内。在AMS阳性和阴性受试者之间,未观察到止血系统测量参数的差异。因此,缺氧引起凝血急性激活的假设可以被否定。